IP Library Granted Patent US 9,687,638
Granted Patent B2
US 9,687,638 · App. 14/006,901 · Granted Jun 27, 2017

Swallowable medication capsule

Inventors: Hans Zou (Chappaqua, NY); Jeff Shimizu (Cortlandt Manor, NY)
Assignee: Medimetrics Personalized Drug Delivery
A61M31/00A61M31/002A61K9/4808
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,687,638
App. No.
14/006,901
Granted
Jun 27, 2017
Kind
B2
Abstract

The invention relates to a swallowable medication capsule capable 200 of dispensing fluid medicine stored in a medication compartment 211 through a valveless exit hole 207 . A vent hole 206 enables ventilation of an actuator cavity 212 which houses an actuator used for displacing a surface 205 which separates the medication cavity 211 and the actuator cavity 212 . By locating the vent and exit holes close to each other so that contact with contracting parts of the gastrointestinal tract and the exterior surface 221 is not able to prohibit a pressure passageway between the vent and exit holes, creation of a pressure difference of pressures in the medication and actuator cavity is prohibited.

Claims (44)

1. A swallowable medication capsule having an elongate shape, the capsule comprising,

a wall forming an exterior surface of the capsule,

a medication compartment configured to contain a medication,

an actuator compartment;

a displacement actuator disposed in the actuator compartment,

a displaceable surface separating the medication compartment from the actuator compartment and arranged to be driven by the displacement actuator, where the displaceable surface is fixed to and forms a fluid-tight seal with an interior surface of the wall and the medication compartment is defined by the displaceable surface and the interior surface of the wall,

a dispense channel providing a passageway between the medication compartment and an exit hole formed at the exterior surface for dispensing the fluid medication to the surroundings, and

a vent channel providing a passageway between the actuator compartment and a vent hole formed at the exterior surface,

where a separation between the exit hole and the vent hole along an elongate axial direction of the elongate shape is less than the length of the medication compartment along the elongate axial direction,

where a part of the dispense channel and/or the vent channel extends within the wall of the capsule between two different locations on the exterior wall surface, and

where the vent channel inlet is disposed along the elongate axial direction on a side of the displaceable surface, opposite the medication compartment.

2. A capsule according to claim 1 , where a surface normal to the exterior surface at the location of the exit hole is substantially parallel with the surface normal to the exterior surface at the location of the vent hole.

3. A capsule according to claim 1 , where a surface normal to the exterior surface at the location of the exit hole and the surface normal to the exterior surface at the location of the vent hole are substantially perpendicular to an elongate axial direction.

4. A capsule according to claim 1 , where the exterior surface of the capsule is formed by a cylindrical shell part having an exterior cylindrical surface, where the displaceable surface is arranged in an interior of the cylindrical part so that the displaceable surface divides the interior into adjacent sections forming the medication compartment and the actuator compartment, and where the exit hole and the vent hole are located on the same exterior cylindrical surface.

5. A capsule according to claim 1 , where the dispense channel extending within the wall of the capsule has different channel directions so that at least one part of the dispense channel provides a fluid passageway in a direction against the gravity, irrespective of the orientation of the swallowable medication capsule.

6. A capsule according to claim 1 , where the dispense channel and/or the vent channel is formed as a groove in an outer shell of the capsule in combination with an inner shell providing a closure of the groove and where the inner shell has a hole providing a fluid passageway between the medication compartment and the groove.

7. A capsule according to claim 1 , where the displaceable surface forms a fluid tight separation between the medication compartment and the actuator compartment.

8. A capsule according to claim 1 , where the capsule is constituted by a first part and a second part which are connectable, and where the medication compartment is a self-confined entity comprised by the second part, and the actuator compartment is a self-confined entity comprised by the first part.

9. A swallowable medication capsule having an elongate shape, the capsule comprising,

a wall forming an exterior surface of the capsule,

a medication compartment for containing a medication,

an actuator compartment for containing a displacement actuator,

a displaceable surface arranged to be driven by the displacement actuator, where the medication compartment is partly defined by the displaceable surface,

a dispense channel providing a passageway between a dispense channel inlet opening to the medication compartment and an exit hole formed at the exterior surface for dispensing the fluid medication to the surroundings, and

a vent channel providing a passageway between a vent channel inlet opening to the actuator compartment and a vent hole formed at the exterior surface,

wherein at least one of a part of the dispense channel or a part of the vent channel extends within the wall such that a spacing between the dispense channel inlet and the vent channel inlet is different from a spacing between the exit hole and the vent.

10. A capsule according to claim 9 , where a surface normal to the exterior surface at the location of the exit hole is substantially parallel with the surface normal to the exterior surface at the location of the vent hole.

11. A capsule according to claim 9 , where a surface normal to the exterior surface at the location of the exit hole and the surface normal to the exterior surface at the location of the vent hole are substantially perpendicular to an elongate axial direction.

12. A capsule according to claim 9 , where the exterior surface of the capsule is formed by a cylindrical shell part having an exterior cylindrical surface, where the displaceable surface is arranged in an interior of the cylindrical part so that the displaceable surface divides the interior into adjacent sections forming the medication compartment and the actuator compartment, and where the exit hole and the vent hole are located on the same exterior cylindrical surface.

13. A capsule according to claim 9 , where the dispense channel extends within the wall of the capsule in different channel directions so that at least one part of the dispense channel provides a fluid passageway in a direction against gravity, irrespective of the orientation of the swallowable medication capsule.

14. A capsule according to claim 9 , where the dispense channel and/or the vent channel is formed as a groove in an outer shell of the capsule in combination with an inner shell providing a closure of the groove and where the inner shell has a hole providing a fluid passageway between the medication compartment and the groove.

15. A capsule according to claim 9 , where the displaceable surface forms a fluid tight separation between the medication compartment and the actuator compartment.

16. A capsule according to claim 9 , where the capsule is constituted by a first part and a second part which are connectable, and where the medication compartment is a self-confined entity comprised by the second part, and the actuator compartment is a self-confined entity comprised by the first part.

17. A capsule comprising:

a wall forming an exterior of the capsule,

a medication compartment configured to contain a medication;

an actuator compartment separated from the medication compartment by a displaceable surface;

a displacement actuator disposed in the actuator compartment to selectively displace the displaceable surface to alter the volume of the medication compartment;

a dispense channel providing a passageway between an opening to the interior of the medication compartment and an exit hole formed at an outer surface of the wall; and

a vent channel providing a passageway between an opening in the actuator compartment and a vent hole formed at the exterior surface,

wherein a separation between the exit hole and the vent hole along an axial direction of the capsule is less than the length of the medication compartment along the elongate axial direction, and

wherein at least one of (a) a part of the dispense channel extends within the wall such that the opening to the interior of the medication compartment and the exit hole are not co-axial and (b) a part of the vent channel extends within the wall such that the opening in the actuator compartment and the vent hole are not co-axial.

18. A capsule according to claim 17 , wherein the dispense channel extending within the wall of the capsule has different channel directions so that at least one part of the channel provides a fluid passageway in a direction against the gravity, irrespective of the orientation of the swallowable medication capsule.

19. A capsule according to claim 17 , wherein the dispense channel and/or the vent channel is formed as a groove in an outer shell of the capsule in combination with an inner shell providing a closure of the groove and where the inner shell has a hole providing a fluid passageway between the medication compartment and the groove.

Assignments (8)
SECURITY INTEREST Recorded Aug 15, 2025
From: BT BIDCO, INC.
To: GLAS USA LLC
Reel/Frame 072473/0861 →
LIEN Recorded Mar 31, 2025
From: BIORA THERAPEUTICS, INC.
To: BT BIDCO LLC
Reel/Frame 070690/0864 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2025
From: BIORA THERAPEUTICS, INC.
To: BT BIDCO, INC.
Reel/Frame 070688/0297 →
SECURITY INTEREST Recorded Dec 21, 2023
From: BIORA THERAPEUTICS, INC.
To: GLAS TRUST COMPANY LLC, AS COLLATERAL AGENT
Reel/Frame 066089/0235 →
CHANGE OF NAME Recorded Sep 19, 2023
From: PROGENITY, INC.
To: BIORA THERAPEUTICS, INC.
Reel/Frame 064961/0451 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2018
From: STOCO 10 GMBH
To: PROGENITY, INC.
Reel/Frame 045831/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2017
From: MEDIMETRICS PERSONALIZED DRUG DELIVERY B.V.
To: STOCO 10 GMBH
Reel/Frame 043463/0820 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2015
From: ZOU, HANS; SHIMIZU, JEFF
To: MEDIMETRICS PERSONALIZED DRUG DELIVERY
Reel/Frame 035240/0835 →
Continuity (2)
Provisional Application 61467057 · Mar 24, 2011
Related Publication 20140135698A1 · May 15, 2014